Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.
Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H. Wasamoto S, et al. Among authors: kagamu h. Front Oncol. 2023 Jan 20;12:1080729. doi: 10.3389/fonc.2022.1080729. eCollection 2022. Front Oncol. 2023. PMID: 36741711 Free PMC article.
A Th1-like CD4+ T-cell Cluster That Predicts Disease-free Survival in Early-stage Lung Cancer.
Yanagihara A, Yamasaki S, Hashimoto K, Taguchi R, Umesaki T, Imai H, Kaira K, Nitanda H, Sakaguchi H, Ishida H, Kobayashi K, Horimoto K, Kagamu H. Yanagihara A, et al. Among authors: kagamu h. Cancer Res Commun. 2023 Jul 19;3(7):1277-1285. doi: 10.1158/2767-9764.CRC-23-0167. eCollection 2023 Jul. Cancer Res Commun. 2023. PMID: 37476074 Free PMC article.
Using the neutrophil-to-lymphocyte ratio to predict the outcome of individuals with nonsquamous non-small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed.
Imai H, Wasamoto S, Tsuda T, Nagai Y, Kishikawa T, Masubuchi K, Osaki T, Miura Y, Umeda Y, Ono A, Minemura H, Yamada Y, Nakagawa J, Kozu Y, Taniguchi H, Ohta H, Kasai T, Kaira K, Kagamu H. Imai H, et al. Among authors: kagamu h. Thorac Cancer. 2023 Sep;14(25):2567-2578. doi: 10.1111/1759-7714.15036. Epub 2023 Jul 19. Thorac Cancer. 2023. PMID: 37469246 Free PMC article.
Comparison of the Efficacy and Toxicity of Concurrent Chemoradiotherapy and Durvalumab and Concurrent Chemoradiotherapy Alone for Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node Metastasis.
Abe T, Iino M, Saito S, Aoshika T, Ryuno Y, Ohta T, Igari M, Hirai R, Kumazaki YU, Miura YU, Kaira K, Kagamu H, Noda SE, Kato S. Abe T, et al. Among authors: kagamu h. Anticancer Res. 2023 Feb;43(2):675-682. doi: 10.21873/anticanres.16205. Anticancer Res. 2023. PMID: 36697072
194 results